Akki you are twisting around and around but you don’t give me (us share holders) a straight answer. Why are you here following PER how do you see this company now and where do you think it will go considering the present management and the few (if any in your opinion) boxes ticked so far, the overall situation of drug’s pipeline and how good in your opinion is the ATL1102 status. It shouldn’t be a problem to enlight us all with a simple comment considering you claim to be a shareholder. We wait.
PER Price at posting:
8.0¢ Sentiment: Buy Disclosure: Held
